Daiichi Sankyo
Joseph Dudash currently serves as the Executive Director of Global Project Management & Leadership at Daiichi Sankyo, Inc., since November 2022. Previously, Joseph held several leadership roles at PPD, including Business Segment Lead for Project Management in the Vaccines Therapeutic Unit, overseeing a global team of 90 project managers, and Director of Project Management for the Hematology/Oncology Therapeutic Unit. Prior experience includes directorial positions at Bristol-Myers Squibb, where Joseph managed medical project teams in oncology and contributed to global medical operations for multiple assets. Joseph's career also includes significant roles at Johnson & Johnson, providing operational leadership for key projects like XARELTO and supporting early development teams. Joseph earned a Ph.D. in Organic Chemistry from Stanford University and a BA in Chemistry from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.